Organon (OGN) reported Q4 adjusted earnings Thursday of $0.90 per diluted share, up from $0.88 a year earlier.
Analysts polled by FactSet expected $0.87.
Revenue for the quarter ended Dec. 31 was $1.59 billion, compared with $1.60 billion a year earlier.
Analysts surveyed by FactSet expected $1.59 billion.
For 2025, Organon said it expects revenue in the range of $6.13 billion to $6.33 billion.
Analysts polled by FactSet expect $6.43 billion.
Organon shares were up over 2% in recent Thursday premarket activity.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。